Advertisement
Canada markets close in 5 hours 34 minutes
  • S&P/TSX

    21,886.53
    +92.63 (+0.43%)
     
  • S&P 500

    5,487.64
    +9.74 (+0.18%)
     
  • DOW

    39,188.08
    +60.28 (+0.15%)
     
  • CAD/USD

    0.7303
    +0.0004 (+0.05%)
     
  • CRUDE OIL

    81.70
    +0.80 (+0.99%)
     
  • Bitcoin CAD

    85,199.92
    +710.74 (+0.84%)
     
  • CMC Crypto 200

    1,294.79
    +28.65 (+2.26%)
     
  • GOLD FUTURES

    2,337.70
    +24.50 (+1.06%)
     
  • RUSSELL 2000

    2,027.04
    +8.92 (+0.44%)
     
  • 10-Yr Bond

    4.2810
    -0.0350 (-0.81%)
     
  • NASDAQ

    17,870.03
    +64.88 (+0.36%)
     
  • VOLATILITY

    12.42
    -0.13 (-1.04%)
     
  • FTSE

    8,214.04
    -11.29 (-0.14%)
     
  • NIKKEI 225

    39,341.54
    -325.53 (-0.82%)
     
  • CAD/EUR

    0.6815
    -0.0016 (-0.23%)
     

Sarepta Catapults 30% After Hitting A 'Grand Slam' Approval In Muscular Dystrophy

Sarepta Catapults 30% After Hitting A 'Grand Slam' Approval In Muscular Dystrophy

Sarepta stock rocketed Friday after hitting a "grand slam" approval that expands the market for its Duchenne muscular dystrophy gene therapy more than tenfold, according to one estimate.